Skip to main content

Table 2 Immunological parameters: pre and post treatment immune marker comparison between the two groups of depressed subjects

From: Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters

 

Omega-3 group (n=22)

Placebo group (n=24)

Tests

 

Pre-treatment

Post-treatment

Pre-treatment

Post-treatment

    
 

Mean (Std.dev.)

Mean (Std.dev.)

Mean (Std.dev.)

Mean (Std.dev.)

1

2

3

4

CD2

84.2 (12.2)

82.9 (12.9)

88.4 (5.5)

87.9 (8.0)

    

CD19

9.0 (10.9)

10.6 (10.2)

6.2 (4.5)

10.9 (18.3)

    

CD3

66.1 (12.8)

66.5 (12.9)

69.8 (8.8)

70.6 (9.6)

    

CD4

41.4 (14.3)

39.1 (16.3)

44.4 (7.9)

41.4 (11.9)

    

CD8

31.9 (13.4)

29.1 (13.9)

29.5 (8.1)

30.9 (9.6)

    

CD16

13.0 (9.3)

16.5 (10.8)

12.4 (6.2)

15.0 (8.6)

*

   

CD4/CD8

1.58 (0.96)

1.68 (1.17)

1.66 (0.85)

1.45 (0.64)

    

IL-5

1.69 (0.60)

1.89 (1.28)

4.36 (8.22)

3.23 (5.90)

    

IL-15

5.86 (3.88)

8.11 (6.14)

5.88 (3.32)

5.99 (5.41)

    
  1. 1 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within n-3 group.
  2. 2 Student’s paired t-test or Wilcoxon signed-rank test to compare post-treatment to baseline values within placebo group.
  3. 3 Unpaired t-test or Wilcoxon rank sum test to compare baseline values between n-3 and placebo group.
  4. 4 Unpaired t-test or Wilcoxon rank sum test to compare changes from baseline values between n-3 and placebo group.
  5. * p<0.05.